These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35955408)

  • 1. Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3.
    Pirone L; Nieto-Fabregat F; Di Gaetano S; Capasso D; Russo R; Traboni S; Molinaro A; Iadonisi A; Saviano M; Marchetti R; Silipo A; Pedone E
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Molecular Details of the Interactions of Selenoglycosides and Human Galectin-3.
    Raics M; Balogh ÁK; Kishor C; Timári I; Medrano FJ; Romero A; Go RM; Blanchard H; Szilágyi L; E Kövér K; Fehér K
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic binding studies of galectin-1, -3 and -7.
    Brewer CF
    Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
    Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
    Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human galectin-1 and galectin-3 promote
    Ayona D; Zarza SM; Landemarre L; Roubinet B; Decloquement P; Raoult D; Fournier PE; Desnues B
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33573443
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors.
    Etulain J; Negrotto S; Tribulatti MV; Croci DO; Carabelli J; Campetella O; Rabinovich GA; Schattner M
    PLoS One; 2014; 9(4):e96402. PubMed ID: 24788652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Anticancer Activity of a Selenium-Containing Galectin-3 and Galectin-9N Inhibitor.
    Di Gaetano S; Pirone L; Galdadas I; Traboni S; Iadonisi A; Pedone E; Saviano M; Gervasio FL; Capasso D
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
    Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactulose as a novel template for anticancer drug development targeting galectins.
    Kishor C; Ross RL; Blanchard H
    Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-wide Identification of Glycosylation-dependent Interactors of Galectin-1 and Galectin-3 on Mesenchymal Retinal Pigment Epithelial (RPE) Cells.
    Obermann J; Priglinger CS; Merl-Pham J; Geerlof A; Priglinger S; Götz M; Hauck SM
    Mol Cell Proteomics; 2017 Aug; 16(8):1528-1546. PubMed ID: 28576849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.
    Bian CF; Zhang Y; Sun H; Li DF; Wang DC
    PLoS One; 2011; 6(9):e25007. PubMed ID: 21949831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring galectin interactions with human milk oligosaccharides and blood group antigens identifies BGA6 as a functional galectin-4 ligand.
    Cagnoni AJ; Massaro M; Cutine AM; Gimeno A; Pérez-Sáez JM; Manselle Cocco MN; Maller SM; Di Lella S; Jiménez-Barbero J; Ardá A; Rabinovich GA; Mariño KV
    J Biol Chem; 2024 Aug; 300(8):107573. PubMed ID: 39009340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications.
    Nowowiejska J; Baran A; Hermanowicz JM; Sieklucka B; Pawlak D; Flisiak I
    Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis Underlying the Binding Preference of Human Galectins-1, -3 and -7 for Galβ1-3/4GlcNAc.
    Hsieh TJ; Lin HY; Tu Z; Huang BS; Wu SC; Lin CH
    PLoS One; 2015; 10(5):e0125946. PubMed ID: 25945972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.
    Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C
    Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Affinity
    Tavares MR; Bláhová M; Sedláková L; Elling L; Pelantová H; Konefał R; Etrych T; Křen V; Bojarová P; Chytil P
    Biomacromolecules; 2020 Feb; 21(2):641-652. PubMed ID: 31904940
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting the CRD F-face of Human Galectin-3 and Allosterically Modulating Glycan Binding by Angiostatic PTX008 and a Structurally Optimized Derivative.
    Miller MC; Zheng Y; Suylen D; Ippel H; Cañada FJ; Berbís MA; Jiménez-Barbero J; Tai G; Gabius HJ; Mayo KH
    ChemMedChem; 2021 Feb; 16(4):713-723. PubMed ID: 33156953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on the binding specificity of β-galactoside analogues with human galectin-1 using molecular dynamics simulations.
    Jino Blessy J; Siva Shanmugam NR; Veluraja K; Michael Gromiha M
    J Biomol Struct Dyn; 2022; 40(20):10094-10105. PubMed ID: 34219624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.